Background: Maternal and neonatal outcomes have improved substantially. During the same period, the caesarean delivery rate soared. The aim of this analysis was to determine whether an increase in caesarean rate was associated with an improvement in perinatal outcome at an institutional level in low-and middle-income countries. Methods: The WHO Global Survey on Maternal and Perinatal Health (WHOGS) and the WHO Multi-Country Survey on Maternal and Newborn Health (WHOMCS) were two multi-country, facility-based, cross-sectional surveys conducted in 2004-08 and 2010-11, respectively. The increase in caesarean rate and the change of prevalence of adverse perinatal outcomes were calculated using a two-point estimator of percent change annualized (PCA) method. Maternal, perinatal, and neonatal composite indexes were used as the outcomes. A linear mixed model was used to assess the association between the change of caesarean rate and the change of perinatal outcome. Results: A total of 259 facilities in 20 countries participated in both surveys, with 217 844 women in WHOGS and 227 734 women in WHOMCS. The caesarean rate in these facilities increased, on average, by 4.0% annually, while the prevalence of adverse perinatal outcomes decreased by 4.6% annually. However, after adjustments for potential confounders, no association was found between the increase in caesarean rate and the change of adverse outcome indexes, regardless of whether starting caesarean rates were already high (above 10%) or not. Conclusions: In low-and middle-income countries, the increases in caesarean rates were not associated with improved perinatal outcomes regardless of whether the starting caesarean rate was already high or not.
estimated 303 000 maternal deaths in 2015, a decline of 43.9% from 1990 levels. 1 Global perinatal mortality statistics have also improved. [2] [3] [4] Neonatal and infant mortality rates have declined by 36% and 46% in lowincome countries, and 43% and 58% in high-income countries between 1990 and 2012. 5 Meanwhile, caesarean delivery rates have increased substantially, even tripled or quadrupled, in many parts of the world. 6 Have increased caesarean rates contributed to better maternal and neonatal outcomes, and if so by how much? Studies of the relationship between caesarean rate and maternal or neonatal mortality have yielded inconsistent results. 7 A recent crosssectional, ecological study estimating annual caesarean rates from data collected during 2005-12 for all 194 World Health Organization (WHO) member states, suggested that national caesarean rates of up to approximately 19 per 100 live births were associated with lower maternal or neonatal mortality among WHO member states. Higher caesarean rates were not associated with maternal or neonatal mortality at a country level. 8 Other population-based ecological studies suggest that when a national caesarean rate is below 10%, an increase in the caesarean rate is associated with a decrease in maternal and neonatal mortality. 9 Further increases in caesarean rates beyond 10% are not associated with additional reductions in mortality, when socioeconomic conditions are adjusted for. 9 This phenomenon has been consistently demonstrated with data from both high and low-income countries, and in cross-sectional and longitudinal analyses. 9, 10 These ecological studies have been limited to using national rates of caesarean and maternal and neonatal mortality, as these measures are routinely reported in civil vital registration systems and readily available for analysis. Although maternal and neonatal mortality rates are generally good indicators for overall maternal and neonatal health at a country level, other outcomes such as maternal and neonatal severe morbidity [11] [12] [13] and quality of life also remain important, particularly as maternal and newborn outcomes are improving. 14, 15 Unfortunately, morbidity data are generally unavailable at a national level, as are data on potential confounders.
Where such data exist, comparisons are often not possible due to the lack of standardized definitions and outcomes. We used data on two consecutive WHO surveys [16] [17] [18] to determine whether an increase in caesarean rate was associated with an improvement in maternal and neonatal morbidity and mortality outcomes at an institutional level in 20 low-and middle-income countries.
Methods

Design and setting
Data for this secondary analysis were derived from two large, cross-sectional, facility-based surveys of maternal and perinatal health: the WHO Global Survey of Maternal and Perinatal Health (WHOGS) and the WHO Multi-Country Survey of Maternal and Newborn Health (WHOMCS). Detailed descriptions of these studies are available elsewhere. [16] [17] [18] Briefly, the WHOGS was conducted to examine the association of the mode of delivery and maternal and perinatal outcomes in 373 health facilities in 24 countries from Africa and Latin America (2004-05) and Asia (2007-08). A stratified, multistage cluster sampling strategy was applied to select the countries, provinces, and health facilities. 16 According to this scheme, the first stage of sampling consisted of countries. This selection was stratified by the WHO regions and the levels of under-five child and adult mortality. Fourteen sub-regions were used to frame the first stage of sampling. From each sub-region, a total of four countries were selected at random for participation in the study, with probability proportional to the country population. When the total number of countries was less than four in any sub-region, all the countries were included. This process resulted in 12 sub-regions having four countries each and two sub-regions having three countries each. A total of 54 countries were initially pre-selected, but, due to operational and budgetary reasons, the WHOGS was implemented in 24 countries from Africa, Asia and Latin America plus Canada. The second sampling stage consisted of randomly selection of two provinces/states (with probability also proportional to the population size), in addition to the country capital city in these 24 countries. A tertiary sampling stage (below the province/ state level) was used for very large provinces/states. For the latter (e.g., Mexico City and Beijing), a fourth sampling stage was implemented. Once the geographical areas were selected, seven health facilities with a minimum of 1000 deliveries per year were randomly selected from each of these areas. If there were less than seven facilities, all facilities of that area were selected. Within each selected facility, detailed information on all births during a specified period was collected before death, hospital discharge or up to 7 days postpartum (whichever came first)by trained health professional staff, with a total number of 287 036 women (290 610 births). Since there was no individual follow-up of women or newborns after hospital discharge, data on newborn and maternal status were only collected from the hospital medical records or staff during the early postpartum period or intensive care units. In 2010-11, WHOMCS was conducted as a subsequent survey based on the WHOGS settings and added seven new countries using the same sampling methodology. WHOGS countries were invited to participate in the WHOMCS. Two countries were unable to join. In total, 359 facilities across 29 countries from Africa, Asia, Latin America, and the Middle East participated. WHOMCS aimed to examine severe maternal and newborn outcomes and maternal near miss cases and deaths regardless of gestational age and mode of delivery (i.e., abortion, ectopic pregnancies). The study included 314 623 women (318 534 births). Data collection was conducted in each facility for a period of 2-4 months, and the study was conducted between May 2010 and December 2011. In addition, in both surveys, institutional information on the availability of obstetric and newborn services, laboratory tests, and human and training resources were also collected.
The 
Data quality
In both studies, a data form was developed and pilot tested. In addition, a Manual of Operations was developed to guide a structured medical record data abstraction process by data collectors. This manual minimized the need for judgment and interpretation by the data collectors. Where incomplete data were identified, data collectors could verify with medical staff. Validity and random cross-checks were conducted to ensure quality of entered data.
Study population
In order to be included in this analysis, a facility must have participated in both WHOGS and WHOMCS and had more than 100 deliveries in each survey. We excluded women whose gestational age at delivery was less than 22 weeks or unknown, or with missing information on exposure and outcome variables of interest: delivery mode, 5-min Apgar score, maternal blood transfusion, maternal admission to ICU/special care unit, newborn status at hospital discharge or on the seventh day of life (alive/dead), neonatal conditions at birth(alive/fresh stillbirth) and maternal status at hospital discharge or on the seventh day postpartum if still in hospital (alive/dead). Most countries participated in both surveys were low-and middle-income countries, except Japan. Because we were interested in lowand middle-income countries in this study, we excluded Japan for further analysis. In addition, the surgical capacity of participating facilities in Angola had a significant change between the two surveys, and the quality of gestational age data in the WHOGS was poor. 19 Therefore, we excluded that country, leaving 259 facilities from 20 low-and middleincome countries which participated in both surveys for further analysis.
Variables and definitions
We used individual data on demographic characteristics, maternal risks, mode of delivery, pregnancy events, and perinatal outcomes. The main exposure of interest in our study was caesarean as final mode of delivery. We used the following information as the main potential confounders: maternal age (<20, 20-34, and ≥35 years), gestational age(<37, 37-41, and ≥42 weeks), years of education(0, 1-6, 7-9, 10-12, and ≥13 years), marital status (without partner, with partner), parity (0, 1-2, and ≥3), previous caesarean (none, one, or more), fetal presentation (vertex, breech, and other), onset of labour (spontaneous, induced, or no labour), birthweight (<2500, 2500-3999, and ≥4000 g), number of neonates (singleton, multiple), chronic hypertension, preeclampsia and data collection year. Level of facility was classified as primary, secondary, tertiary and other referral level. We used gross domestic product (GDP) that were reported by the World Bank as a proxy for the socio-economic condition for each country.
The main outcomes of this study included one primary and two secondary outcomes. Since severe maternal and neonatal morbidity and mortality were rare, we used a weighted perinatal adverse outcome index proposed by Mann and colleagues 20 as the primary outcome (Table S1 ). Several adverse outcomes listed in the Table S1 were not available in both surveys. Thus, the composite outcome included Apgar score at 5 min <7, maternal and/or neonatal death at hospital discharge or on the seventh day of life (alive/ dead), maternal blood transfusion, admission of the mother to ICU/special care unit and neonatal conditions at birth (alive/fresh stillbirth).We calculated the perinatal adverse outcome index as the sum of weighted adverse outcome scores divided by the number of deliveries for each facility. Maternal and neonatal adverse outcome indexes were also created as the secondary outcomes. The maternal index was composed of maternal death at hospital discharge or on the seventh day of life (alive/dead), maternal blood transfusion, and admission of the mother to ICU/special care unit, while the neonatal index included Apgar score at 5 min <7, neonatal death at hospital discharge or on the seventh day of life (alive/ dead), and neonatal conditions at birth (alive/fresh stillbirth).
Statistical analysis
The facility was the unit of analysis. The exposure and covariates are all calculated as a rate or proportion in each facility. The covariates included the proportion of women in the facility aged ≤19 and ≥35 years, education <7 years and >12 years, marital status (without partner), primiparity, any prior caesarean, non-cephalic fetal presentation, gestational age <37 weeks and >41 weeks, birthweight <2500 g and ≥4000 g, multiple births, chronic hypertension, preeclampsia, level of facility, and GDP. Since the interval between the two surveys varied from country to country, we used a two-point estimator of Percent Change Annualized (PCA) 21 to examine how the annual rate of change in caesarean rate was associated with the annual rate of change in the prevalence of adverse perinatal outcomes at the facility level between two surveys,
A similar equation was used by WHO in calculating maternal mortality trends. 6, 22 With the underlying assumption that the caesarean rate changed linearly, the statistical model was as: PCA of adverse perinatal outcome composite index = intercept + PCA of caesarean rate + PCA of covariates. However, the PCA function became undefined when a zero rate was observed at either survey. To avoid this, we used a continuity correction by adding a small amount (0.0001) to facilities with a zero rate. All covariates and outcomes were aggregated and reported at "facility" level as described above. Covariates were included as fixed terms into a linear mixed model with random intercepts for country. The analyses were weighted by the average number of women of the two surveys for each facility. We also conducted stratified analyses according to the facility caesarean rate (≤10% vs.>10%). To be more statistically conservative, the latter was calculated as the geometric mean of the caesarean rates (the square root of the caesarean rates) of the two surveys.
Results
Figure 1 illustrates our selection process of the study population. In total, 217 844 women in WHOGS and 227 734 women in WHOMCS from 259 facilities in 20 low-and middle-income countries were included in the following analysis. Table S2 provides detailed information of the facilities by country. Table 1 presents the characteristics of women at the individual level. These characteristics were reported because they were included in both surveys. More facilities became tertiary hospitals, increased from 31.1% (WHOGS) to 55.9% (WHOMCS). The proportion of women aged ≥35 years changed from 9.9% to 10.7%. The proportion of education more than 12 years changed from 13.4% to 17.0%. In the WHOGS and WHOMCS surveys 43.7% and 45.5% of women were nulliparas, respectively. The proportion of women with previous caesarean changed from 10.5% to 12.9%. The prevalence of preeclampsia decreased from 2.8% to 2.1%, and chronic hypertension from 0.5% to 0.4%.Women with spontaneous onset of labour changed from 80.7% to 77.6%. The overall caesarean rate increased from 27.0% to 31.7% between the two surveys. Multiple births had a reduction from 2.3% to 1.5%. Birthweight less than 2500 g was from 10.5% in WHOGS to 11.1% in WHOMCS. In WHOGS, 95.0% had cephalic fetal presentation compared with 95.5% in WHOMCS. Table 2 presents the characteristics of the facilities in each survey. Due to a skewed distribution of most variables, we used median and interquartile range (Q1 and Q3). The median caesarean rate by facility increased from 24.7% in WHOGS to 30.5% in WHOMCS.
During that period, the caesarean rate in these facilities increased by 4.0% annually, on average, while the prevalence of adverse perinatal outcomes decreased by 4.6% annually. Figure 2 illustrates the relationship between PCA of caesarean rate and PCA of perinatal, maternal, and neonatal adverse outcome indices at the facility level. The scatter plot shows no association between PCA of caesarean rate and PCA of adverse outcome. Table 3 summarises the unadjusted and adjusted associations. An increase in caesarean rate was not associated with a change in perinatal adverse outcome index in the unadjusted analysis. When adjusted for confounders, the results were similar (ß = 0.1, 95% CI À0.7, 0.9). Again, there was no association between PCA of caesarean rate and PCA of maternal (ß = 0.5, 95% CI À0.1, 1.1) and neonatal (ß = À1.0, 95% CI À8.2, 6.3) adverse outcomes. Furthermore, we stratified the caesarean rates by less or more than 10%. This stratification was based on our previous findings that when caesarean rate was below 10%, an increase in caesarean rate was associated with a decrease in mortality rates, but when caesarean rate was above 10%, this association virtually disappeared. However, the current analysis failed to show any association regardless whether the caesarean rate was below or above 10% or 19% in both multiparous and nulliparous women (Tables S3 and  S4 ).
Comment
Principal findings
We found that at the hospital level, increases in caesarean rates in low-and middle-income countries were not associated with changes in perinatal adverse outcome index irrespective of the baseline caesarean rate. This finding remained unchanged when we examined at the maternal and neonatal adverse outcome indices separately.
Interpretation
As more and more developing countries have improved economic conditions in recent years, maternal and newborn mortality has decreased. Despite that mortality is considered to be a powerful socio-economic and health indicator within a population, death is a rare event and the isolated cases may not reflect the quality of obstetrical assistance. 20, 23 Morbidity has been suggested as an alternative measure. 24 Preventing morbidity and improving quality of care have become more important. Would a higher caesarean rate be necessary to achieve this goal? And how high should it be? Unfortunately, little is known in this regard. Some European countries 25 and Japan 26 have maintained a caesarean rate below 20% at country level in the past two decades while continuing to improve perinatal outcomes. As these countries have some of the lowest perinatal mortality rates in the world, it may be assumed that generally speaking, caesarean rates may not have to go beyond 20% in order to achieve excellent perinatal outcomes. In fact, the mode of delivery may play a less important role in improving perinatal outcomes at a population level. The caesarean rate is usually already much higher in the high risk pregnancies. 27 For example, in China, the caesarean rate in women with severe preeclampsia was 80% in comparison to 46.2% in the general population. 27, 28 Will an even higher caesarean rate be necessary in these pregnancies? Probably not. Ample evidence indicates that a high caesarean rate in some developing countries is due to caesarean without clear medical indication. 29, 30 In our data, 85%
of the facilities had a caesarean rate over 10%. It is likely that some of these caesarean were not medically indicated. A previous WHOG Sanalysis 31 showed that a total of 1.0 percent of all deliveries had caesarean without medical indications, and the overall proportion of women delivering by caesarean without medical indication ranged from 0.01 to 2.10%. In the Chinese institutions participating in WHOGS this figure was exceptionally higher at 11.6%. 31 The previous study demonstrated that caesarean without medical indication was associated with an increased risk of short-term adverse maternal outcomes. 31 Not only will it increase perinatal morbidity and mortality, 32, 33 but also contribute to health care costs. 34 In UK, each additional vaginal birth instead of caesarean saves more than £1200. 35 For a lower-income country like Chile, the difference in cost between a vaginal delivery and a caesarean is about US$350. 36 If unnecessary Figure 2 . Relationship between the percent change annualized (PCA) of caesarean delivery rate and PCA of perinatal, maternal, and neonatal adverse outcome indices (AOI). Perinatal adverse outcome index: Apgar score at 5 min <7, maternal and/or neonatal death at hospital discharge or on the seventh day of life, maternal blood transfusion, admission of the mother to ICU/special care unit, and fresh stillbirth. Maternal adverse outcome index: maternal death at hospital discharge or on the seventh day of life, maternal blood transfusion, admission of the mother to ICU/special care unit. Neonatal adverse outcome index: Apgar score at 5 min <7, neonatal death at hospital discharge or on the seventh day of life, fresh stillbirth.
caesarean can be reduced, financial and human resources could be used in other parts of the health system. It is worth mentioning that PCA was used as the main metric of interest. PCA is often used to measure trends in disease or mortality rates. For making comparisons or studying associations between very different rates, the absolute change in rates may not be appropriate. Thus, a relative change like PCA is better suited for such comparisons. This measure is often used in epidemiological literature and well-recognized as a robust way of comparing rates. 37 Limitations of the data However, our study had several limitations. First, some additional variables that may be potential confounders for the association between caesarean rate and perinatal outcomes were included in only one survey but not both, precluding their use in the present study. Thus, potential residual confounding is possible. However, since our result is already negative, adjustments for more potential confounders would unlikely change our conclusion. Second, the number of facilities with a caesarean rate lower than 10% was small. The stratified analysis in this subgroup may have been underpowered. Third, the weighted adverse perinatal outcome index used in this study 21 lumped intrapartum fetal and neonatal deaths together. Given that the intrapartum stillbirth rate is considered as a good indicator for quality of intrapartum care, of which caesarean is an important component, future studies are worth exploring "fresh stillbirth" rates in relation to caesarean. Finally, it is important to point out that we used the weighted perinatal adverse outcome index as our primary outcome, but data on uterine rupture, birth trauma, return to the operating/labour and delivery room, admission to NICU (in neonates that weighed ≥2500 g and stayed in NICU for over 24 h), and third or fourth degree perineal lacertations was not available in both surveys. Thus, our index was based on five maternal and neonatal outcomes only. Nonetheless, we tried three different composite outcomessevere maternal outcome, severe neonatal outcome, and combined maternal and neonatal outcome. We also tested models using un-weighted adverse outcome indexes. The results were similar, reassuring the validity of our conclusion.
Strengths of the study
The current study is unique in that it linked the records of two large sequential WHO multi-country surveys to examine changes in caesarean rate and the changes in adverse maternal and perinatal outcomes Table 3 . Associations between Percent Change Annualised (PCA) of caesarean delivery rate and PCA of adverse outcome index by levels of caesarean rate at the facility level Adjusted for PCA of women in the facility aged ≤19, and ≥35 years, education <7, and ≥13 years, marital status, parity, any prior caesarean, fetal presentation, year of survey, log gross domestic product, gestational age <37 weeks, and ≥42 weeks, birthweight <2500 g, and ≥4000 g, multiple births, chronic hypertension, preeclampsia and level of facility change (tertiary or other referral level) per year. a Perinatal adverse outcome index: Apgar score at 5 min <7, maternal and/or neonatal death at hospital discharge or on the seventh day of life, maternal blood transfusion, admission of the mother to ICU/special care unit, fresh stillbirth. Maternal adverse outcome index: maternal death at hospital discharge or on the seventh day of life, maternal blood transfusion, admission of the mother to ICU/special care unit.
in 20 low-and middle-income countries. A very large sample size in both surveys made the analysis possible, and results could potentially shed important light on changes in caesarean usage in those countries.
Conclusions
This facility-based ecological analysis indicates that in low-and middle-income countries, the increases in caesarean rates were not associated with improved perinatal outcomes regardless of whether the starting caesarean rate was already high or not. 
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